Journal
LIFE SCIENCES
Volume 283, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2021.119851
Keywords
Cardiovascular diseases; Sleep disorders; Comorbidity; Gut microbiome; Extracellular vesicles; Orexin
Funding
- National Natural Science Foundation of China [81772044, 81974171, 81703482]
Ask authors/readers for more resources
The review on the comorbidity of sleep disorders and cardiovascular diseases emphasizes the critical roles of inflammation, sympathetic activation, and endothelial dysfunction in the relationship between the two. In addition to existing mechanisms, novel potential mechanisms such as gut microbiota, orexin, and extracellular vesicles are summarized, providing a theoretical basis for further research and clinical investigations.
Sleep disorders frequently comorbid with several cardiovascular diseases (CVDs), attracting increasing scientific attention and interest. Sleep disorders include insomnia, sleep-disordered breathing, restless legs syndrome, etc. It is well known that inflammation, sympathetic activation, and endothelial dysfunction play critical roles in sleep disorders, all of which are predisposing factors for CVDs. The comorbidity of sleep disorders and CVDs may have a bidirectional relationship. Patients with CVDs may have a high incidence of sleep disorders and vice versa. This review focused on the comorbidity of sleep disorders and CVDs and discussed the potential pathophysiological mechanisms and therapeutic strategies. In addition to the existing mechanisms, this review summarized novel potential mechanisms underlying comorbidities, such as gut microbiota, orexin, and extracellular vesicles, which may provide a theoretical basis for further basic research and clinical investigations on improving therapeutic outcomes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available